Qube Research & Technologies (QRT)
RNTX

Qube Research & Technologies (QRT)’s Rein Therapeutics RNTX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio RNTX Stock Details RNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32K Buy
+30,787
New +$37.3K ﹤0.01% 3173
2021
Q4 		– Sell
-1,264
Closed -$26K – 3053
2021
Q3 		$26K Buy
+1,264
New +$27.7K ﹤0.01% 1945
2021
Q2 		– Sell
-618
Closed -$18K – 2886
2021
Q1 		$18K Sell
618
-2,768
-82% -$94.8K ﹤0.01% 1821
2020
Q4 		$70K Sell
3,386
-7,827
-70% -$196K ﹤0.01% 1674
2020
Q3 		$289K Buy
11,213
+9,644
+615% +$227K ﹤0.01% 1262
2020
Q2 		$37K Buy
+1,569
New +$25.6K ﹤0.01% 1632

Other funds holding RNTX

VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
SM
Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return

Qube Research & Technologies (QRT)'s RNTX Position: Q2 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Rein Therapeutics (RNTX) in Q2 2026: 30,787 shares worth $32K. The stake represents ﹤0.01% of the portfolio and ranks #3173 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in RNTX as recently as Q3 2021.

Qube Research & Technologies (QRT) first reported a position in RNTX in Q2 2020 and has held it in 6 quarters since. The position peaked at $289K in Q3 2020. 60 funds tracked by Wall St. Rank hold RNTX as of Q2 2026.

  • Qube Research & Technologies (QRT) held 30,787 shares of Rein Therapeutics worth $32K as of Q2 2026.
  • Rein Therapeutics was a new Qube Research & Technologies (QRT) position in Q2 2026.
  • Rein Therapeutics made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #3173 holding.
  • Qube Research & Technologies (QRT) first reported a position in Rein Therapeutics in Q2 2020 and has held it in 6 quarters since.
  • Qube Research & Technologies (QRT)'s Rein Therapeutics position peaked at $289K in Q3 2020.
  • 60 funds tracked by Wall St. Rank held Rein Therapeutics as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.